Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Nutritional implications of olives and sugar: attenuation of post-prandial glucose spikes in healthy volunteers by inhibition of sucrose hydrolysis and glucose transport by oleuropein.

Kerimi A, Nyambe-Silavwe H, Pyner A, Oladele E, Gauer JS, Stevens Y, Williamson G.

Eur J Nutr. 2019 Apr;58(3):1315-1330. doi: 10.1007/s00394-018-1662-9. Epub 2018 Mar 9.

2.

Physicians' duty to recontact and update genetic advice.

Stevens YA, Senner GD, Marchant GE.

Per Med. 2017;14(4):367-374. doi: 10.2217/pme-2017-0012. Epub 2017 Jun 8.

3.

Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals.

Salden BN, Troost FJ, de Groot E, Stevens YR, Garcés-Rimón M, Possemiers S, Winkens B, Masclee AA.

Am J Clin Nutr. 2016 Dec;104(6):1523-1533. Epub 2016 Oct 26.

PMID:
27797708
4.

A new window of opportunity to reject process-based biotechnology regulation.

Marchant GE, Stevens YA.

GM Crops Food. 2015;6(4):233-42. doi: 10.1080/21645698.2015.1134406.

5.

Barriers beyond clinical control affecting timely hospital discharge for a patient requiring guardianship.

Chen JJ, Kwon A, Stevens Y, Finn CT.

Psychosomatics. 2015 Mar-Apr;56(2):206-9. doi: 10.1016/j.psym.2014.07.006. Epub 2014 Jul 24. No abstract available.

PMID:
25596023
6.

Involuntary exposures to love-enhancing or anti-love agents.

Marchant GE, Stevens YA.

Am J Bioeth. 2013;13(11):26-7. doi: 10.1080/15265161.2013.839758. No abstract available.

PMID:
24161175
7.

Toxicological Profile for Lead.

Abadin H, Ashizawa A, Stevens YW, Llados F, Diamond G, Sage G, Citra M, Quinones A, Bosch SJ, Swarts SG.

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2007 Aug.

8.

Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus.

Houghton R, Gori Savellini G, Chen H, Stevens Y, Moon J, Morkowski S, Raychaudhuri S, Valentini M, Cusi MG.

J Virol Methods. 2013 Jan;187(1):182-4. doi: 10.1016/j.jviromet.2012.09.015. Epub 2012 Sep 25.

PMID:
23022418
9.

Effects of vitamin D3 supplementation and UVb exposure on the growth and plasma concentration of vitamin D3 metabolites in juvenile bearded dragons (Pogona vitticeps).

Oonincx DG, Stevens Y, van den Borne JJ, van Leeuwen JP, Hendriks WH.

Comp Biochem Physiol B Biochem Mol Biol. 2010 Jun;156(2):122-8. doi: 10.1016/j.cbpb.2010.02.008. Epub 2010 Mar 4.

PMID:
20206712
10.

Lateral flow immunoassay for diagnosis of Trypanosoma cruzi infection with high correlation to the radioimmunoprecipitation assay.

Houghton RL, Stevens YY, Hjerrild K, Guderian J, Okamoto M, Kabir M, Reed SG, Leiby DA, Morrow WJ, Lorca M, Raychaudhuri S.

Clin Vaccine Immunol. 2009 Apr;16(4):515-20. doi: 10.1128/CVI.00383-08. Epub 2009 Feb 11.

11.

Findings and accomplishments of ATSDR's Superfund-mandated Substance-Specific Applied Research Program.

Stevens YW, Williams-Johnson MM, De Rosa CT, Cibulas W Jr.

Int J Hyg Environ Health. 2002 Mar;205(1-2):29-39.

PMID:
12018014
12.

Adenosine kinase deficiency is associated with developmental abnormalities and reduced transmethylation.

Moffatt BA, Stevens YY, Allen MS, Snider JD, Pereira LA, Todorova MI, Summers PS, Weretilnyk EA, Martin-McCaffrey L, Wagner C.

Plant Physiol. 2002 Mar;128(3):812-21.

13.
14.

Adenosine kinase of Arabidopsis. Kinetic properties and gene expression.

Moffatt BA, Wang L, Allen MS, Stevens YY, Qin W, Snider J, von Schwartzenberg K.

Plant Physiol. 2000 Dec;124(4):1775-85.

15.

Phenotypic instability and rapid gene silencing in newly formed arabidopsis allotetraploids.

Comai L, Tyagi AP, Winter K, Holmes-Davis R, Reynolds SH, Stevens Y, Byers B.

Plant Cell. 2000 Sep;12(9):1551-68.

16.

Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals.

Ostrowski SR, Wilbur S, Chou CH, Pohl HR, Stevens YW, Allred PM, Roney N, Fay M, Tylenda CA.

Toxicol Ind Health. 1999 Nov;15(7):602-44. Review.

PMID:
10677885
17.

Role of risk assessment in public health practice.

De Rosa CT, Stevens YW, Johnson BL.

Toxicol Ind Health. 1998 May-Jun;14(3):389-412. Review. No abstract available.

PMID:
9569446
18.

Health evaluation of 1,4-dioxane.

DeRosa CT, Wilbur S, Holler J, Richter P, Stevens YW.

Toxicol Ind Health. 1996 Jan-Feb;12(1):1-43. Review. No abstract available.

PMID:
8713712
19.

The Agency for Toxic Substances and Disease Registry's role in development and application of biomarkers in public health practice.

Derosa CT, Stevens YW, Wilson JD, Ademoyero AA, Buchanan SD, Cibulas W Jr, Duerksen-Hughes PJ, Mumtaz MM, Neft RE, Pohl HR, et al.

Toxicol Ind Health. 1993 Nov-Dec;9(6):979-94. Review.

PMID:
8191504
20.

Cancer policy framework for: public health assessment of carcinogens in the environment.

DeRosa CT, Stevens YW, Johnson BL.

Toxicol Ind Health. 1993 Jul-Aug;9(4):559-75.

PMID:
8296311
21.

In vitro differential metabolism of merbarone by xanthine oxidase and microsomal flavoenzymes. The role of reactive oxygen species.

Muindi JF, Stevens YW, Warrell RP Jr, Young CW.

Drug Metab Dispos. 1993 May-Jun;21(3):410-4.

PMID:
8100495
22.

Phase I clinical and pharmacological study of merbarone.

Dimaggio JJ, Warrell RP Jr, Muindi J, Stevens YW, Lee SJ, Lowenthal DA, Haines I, Walsh TD, Baltzer L, Yaldaei S, et al.

Cancer Res. 1990 Feb 15;50(4):1151-5.

23.

Induction of profound hypouricemia by a non-sedating thiobarbiturate.

Warrell RP Jr, Muindi J, Stevens YW, Isaacs M, Young CW.

Metabolism. 1989 Jun;38(6):550-4.

PMID:
2725294
24.

4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia.

Berman E, Raymond V, Daghestani A, Arlin ZA, Gee TS, Kempin S, Hancock C, Williams L, Stevens YW, Clarkson BD, et al.

Cancer Res. 1989 Jan 15;49(2):477-81.

25.

Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

Young CW, Fanucchi MP, Declan Walsh T, Baltzer L, Yaldaei S, Stevens YW, Gordon C, Tong W, Rifkind RA, Marks PA.

Cancer Res. 1988 Dec 15;48(24 Pt 1):7304-9.

PMID:
3191501
26.

Quantitation of merbarone in human plasma by high-performance liquid chromatography.

Stevens YW, Walsh TD, Fanucchi MP.

J Chromatogr. 1987 Apr 24;416(1):203-6. No abstract available.

PMID:
3597638
27.

"Defective" receptors in steroid-resistant conditions may be proteolytic artifacts.

Sherman MR, Tuazon FB, Stevens YW, Carlino JA, Niu EM.

Adv Exp Med Biol. 1986;196:23-51. Review.

PMID:
3012978
28.
30.

Absence in glucocorticoid-resistant mouse lymphoma P1798 of a glucocorticoid receptor domain responsible for biological effects.

Okret S, Stevens YW, Carlstedt-Duke J, Wrange O, Gustafsson JA, Stevens J.

Cancer Res. 1983 Jul;43(7):3127-31.

31.

Rural women in Africa and technological change: some issues.

Date-bah E, Stevens Y.

Labour Soc. 1981 Apr-Jun;6(2):149-62.

PMID:
12311009
32.

Immunochemical differences between glucocorticoid receptors from corticoid-sensitive and -resistant malignant lymphocytes.

Stevens J, Eisen HJ, Stevens YW, Haubenstock H, Rosenthal RL, Artishevsky A.

Cancer Res. 1981 Jan;41(1):134-7.

34.

Characterization of cytosolic and nuclear glucocorticoid-binding components in human leukemic lymphocytes.

Stevens J, Stevens YW, Rosenthal RL.

Cancer Res. 1979 Dec;39(12):4939-48. No abstract available.

36.

Nuclear glucocorticoid binding in experimental and human leukemia.

Stevens J, Stevens YW, Rhodes J, Sloan E, Rosenthal RL, Steiner G.

Mt Sinai J Med. 1979 Mar-Apr;46(2):217-24. No abstract available.

PMID:
312451
38.

Nuclear glucocorticoid binding in chronic lymphatic leukemia lymphocytes.

Stevens J, Stevens YW, Sloan E, Rosenthal R, Rhodes J.

Endocr Res Commun. 1978;5(2):91-108.

PMID:
720288
40.

Cortisol-induced lymphocytolysis of P1798 tumor cells in glucose-free, pyruvate-free medium.

Stevens J, Stevens YW.

J Natl Cancer Inst. 1975 Jun;54(6):1493-4.

PMID:
1173377
41.
42.

Role of nucleoside transport in glucocorticoid-induced regression of mouse lymphoma P1798.

Stevens J, Stevens YW, Behrens U, Hollander VP.

Biochem Biophys Res Commun. 1973 Feb 5;50(3):799-806. No abstract available.

PMID:
4734679
43.

Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.

Stevens J, Stevens YW, Hollander VP.

Cancer Res. 1973 Feb;33(2):370-4. No abstract available.

44.

Glucocorticoid inhibition of precursor incorporation into nuclear RNA of P1798 lymphosarcoma.

Stevens J, Mashburn LT, Stevens YW, Hollander VP.

Biochim Biophys Acta. 1971 Mar 11;232(2):338-46. No abstract available.

PMID:
5108117

Supplemental Content

Loading ...
Support Center